mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.3 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.3 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.3 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.3 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |